Bioventus(NASDAQ) BVS

Market Cap$923.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-32%
5 Year-3%
1 Year+93%
1 Month-4%
Premium Feature
Moneyball Superscore
59/100
$13.51
+2.89%
+0.38Today
After hours$13.52+$0.01 (+0.07%)
Bioventus last closing stock price
MetricPriceDate
Last closeUSD 13.522026-10-05
Bioventus stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.57%USD 14.022026-09-28
1 month-3.91%USD 14.072026-09-04
3 month+17.67%USD 11.492026-07-07
Year to date+81.72%USD 7.442025-12-31
1 year+92.59%USD 7.022025-10-03
3 year+331.95%USD 3.132023-10-06
5 year-2.94%USD 13.932021-10-06
Since inception-31.65%USD 19.212021-02-11

Bioventus Financials at a Glance

Market Cap

$923.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$581.85

Net Income (TTM)

$61.47

EPS (TTM)

$0.78

P/E Ratio

17.44

Dividend

$0.00

Beta (Volatility)

1.15 (Average)

Price

$13.51

Volume

105.104

Open

$13.13

Previous Close

$13.52

Daily Range

$13.07 - $13.58

52-Week Range

$6.37 - $15.89

Estimated Earnings Date

N/A

BVS News

doctor scientist microscope gloves mask (1)

Why Shares of Bioventus Fell 14% on Wednesday

James HalleyNov 9, 2022
Knee x-ray

Why Bioventus Stock Is Sinking Today

Keith SpeightsApr 4, 2022
Physical therapy medical professional examining knee of patient

Will a Powerful Acquisition Make This Early 2021 IPO a Buy?

Jeffrey LittleAug 17, 2021

BVS: Motley Fool Moneyball Superscore

59

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bioventus

Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

930

CEO

Robert E. Claypoole, MBA

Website

www.bioventus.com

BVS Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

27.96%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

5.73%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$923.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

68.31M

Volume

105.104

Avg. Volume

653.98K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Bioventus Performance Analysis

Bioventus annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 512,117,00018.8%
20232023-12-31USD 512,345,0000.0%
20242024-12-31USD 573,280,00011.9%
20252025-12-31USD 568,087,000-0.9%
Bioventus annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -2.59N/A
20232023-12-31USD -2.49-3.5%
20242024-12-31USD -0.56-77.6%
20252025-12-31USD 0.33N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$153.21

+1.0%

Gross Profit

$104.63

+1.0%

Gross Margin

68.29%

+1.0%

Market Cap

$923.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$0.69

N/A

Employees

930

N/A

Net Income

$36.21

+3.9%

EBITDA

$29.68

+1.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$293.21

-25.5%

Total Debt

$263.75

+0.7%

Accounts Receivable

$138.41

+1.0%

Inventory

$79.81

+0.8%

Long Term Debt

$240.86

+0.8%

Short Term Debt

$22.89

+0.5%

Return on Assets

7.89%

-374.4%

Return on Invested Capital

-6.48%

+1.0%

Free Cash Flow

$18.91

+0.7%

Operating Cash Flow

$19.87

+0.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,777.74+0.01%
^DJIDJI
$51,304.21+0.00%
^IXICNASDAQ
$27,461.27+0.01%
BTCBitcoin
$85,510.00+0.00%

Questions About BVS

What is the current price of Bioventus?

Bioventus is trading at $13.52 per share.

What is the 52-week range for Bioventus?

Over the past 52 weeks, Bioventus has traded between $6.37 and $15.89.

How much debt does Bioventus have?

As of the most recent reporting period, Bioventus reported total debt of $263.75M.

How much cash does Bioventus have on hand?

Bioventus reported $29.46M in cash and cash equivalents in its most recent financial results.

What is Bioventus’s dividend yield?

Bioventus does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services